A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy
mediaposted on 2021-05-10, 15:33 authored by Adis Rapid Journals on behalf of:, Chin-Chou Wang, Li-Chung Chiu, Pi-Hung Tung, Scott Chih-Hsi Kuo, Chia-Hsun Chu, Allen Chung-Cheng Huang, Chih-Liang Wang, Chih-Hung Chen, Cheng-Ta Yang, Ping-Chih Hsu
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.